Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2017	Dec. 31, 2016
Sales, net	$ 10,800	$ 12,372	$ 20,570	$ 25,053
Cost of sales	9,752	10,902	18,517	21,432
Gross profit	1,048	1,470	2,053	3,621
Selling and administrative expenses	850	900	1,644	1,693
Operating income	198	570	409	1,928
Other income (expense), net
Interest expense	(229)	(227)	(462)	(459)
Change in fair value of derivative liabilities	185	(364)	67	(731)
Impairment on investment in iBio, Inc.	(168)		(251)
Other income, net	4	15	4	31
Other income (expense), net	(208)	(576)	(642)	(1,159)
(Loss) income before income taxes	(10)	(6)	(233)	769
Income tax expense, net	338	71	294	197
Net (loss) income	$ (348)	$ (77)	$ (527)	$ 572
Basic net (loss) income per common share (in dollars per share)	$ (0.02)	$ 0	$ (0.02)	$ 0.03
Diluted net (loss) income per common share (in dollars per share)	$ (0.02)	$ 0	$ (0.02)	$ 0.03
Weighted average common shares outstanding - basic (in shares)	21,135,174	21,106,098	21,135,174	21,105,636
Add: Equivalent shares outstanding
Shares issuable upon conversion of Convertible Debt - CD Financial, LLC (in shares)				567,964
Weighted average common shares outstanding - diluted (in shares)	21,135,174	21,106,098	21,135,174	21,673,600